XT
IMNM icon

XTX Topco’s Immunome IMNM Stock Holding History

XTX Topco’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
60,498
+42,696
+240% +$950K 0.02% 1182
2025
Q4 		$382K Sell
17,802
-52,712
-75% -$925K 0.01% 1851
2025
Q3 		$826K Buy
+70,514
New +$701K 0.04% 700
2024
Q4 		– Sell
-24,823
Closed -$363K – 2580
2024
Q3 		$363K Buy
+24,823
New +$353K 0.03% 1062

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

XTX Topco's IMNM Position: Q1 2026 in Review

XTX Topco increased its Immunome (IMNM) stake by 240% in Q1 2026, buying an estimated $950K and bringing the position to 60,498 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #1182.

XTX Topco first reported a position in IMNM in Q3 2024 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • XTX Topco held 60,498 shares of Immunome worth $1.32M as of Q1 2026.
  • XTX Topco bought 42,696 Immunome shares in Q1 2026, an estimated $950K.
  • Immunome made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1182 holding.
  • XTX Topco first reported a position in Immunome in Q3 2024 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.